Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) can occur in patients with congenital heart disease (CHD). Would you like to learn more about them, their causes, and treatment options? If so, you will want to attend this webinar. While PAH is not common and only some patients with CHD are at risk, PH can affect any patient with CHD. It mostly affects those with left heart disease (valve or ventricular dysfunction), lung disease, and obstructive sleep apnea. Join us to learn whether you are at risk of these conditions and what you can do to prevent them.
Medical providers, click here for a flyer to use at your ACHD program!
About the Presenter
Jeremy Nicolarsen, MD, is a member of the ACHA Medical Advisory Board. He is the Director of the Providence Adult and Teen Congenital Heart Program (PATCH), a nationally accredited ACHA ACHD Comprehensive Care Center in Spokane, WA, that serves the Inland Northwest, including eastern and south/central Washington, western Montana, and the Idaho panhandle. Dr. Nicolarsen grew up in Wyoming, went to college at Creighton University (Go Jays!), attended medical school and completed a Med-Peds residency at the University of Chicago, and completed fellowships in Pediatric Cardiology, Cardiovascular Disease (adult cardiology), and ACHD at Children’s Colorado/University of Colorado.